Revenue qualityDanger
매출 흑자인데 영업CF 적자 (OCF/매출 -48%). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Alvotech
ALVO · Nasdaq$5.32-1.12%
2026-09-04 closeAlvotech last closed at $5.32 (-1.12%) on 2026-09-04. Signals today: MA aligned. Listed on Nasdaq; price, financials and dividends update daily after market close.
Loading chart…
CloseMA20MA60MA120
Super Strong RS 81 · top 19%
New high + volume — the real recordrecord · not a prediction
Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p
Every new-high-plus-volume pick we actually published (US market) — not this stock alone.
Signal history
| Date | Signal | +20 trading days |
|---|---|---|
A record, not a prediction.
How this is calculated
"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.
Trade plan
Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.
A calculator · not advice or a guarantee
Financials & valuation at a glance
A-
Overall: 건강관리 188/745 · top 25%
Factor composite · relative position in sector
PER — · PBR — — own-history percentile 51/100 · —/100
Open self-history band
PER51/100
PBR—/100
Factual information · not investment advice
Past reported results · not investment advice
More — deeper indicators
Financial safety
Reference indicatorAs of 2024Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -5.32
Distress
Grey
Safe
- Altman Z''
- -5.32
- Beneish M-Score
- -0.04
- Sloan accrual
- 0.41%
Statistical manipulation-risk signal
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Earnings quality · Piotroski F-Score
6/9Moderate
Piotroski measures year-over-year financial improvement, not absolute quality.
Financial improvement score6/9
Profitability
- Positive ROANot passed
- Positive OCFNot passed
- Improving ΔROAPass
- Accruals (OCF > net income)Not passed
Leverage & liquidity
- Lower debtPass
- Higher current ratioPass
- No new sharesPass
Efficiency
- Higher gross marginPass
- Higher asset turnoverPass
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Forensic signals
Anomaly and structural signals observed in the financial statements.
Balance sheetDanger
자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.
Margin trendWarning
영업외손익 급변 (영업이익 대비 21345% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
Industry structure
USAs of 2026-09-05건강관리
This stock is in 건강관리: revenue rank 167 of 543, share 0%.
167 / 5430%revenue share
Who dominates this industry?
- 1CVS Health14.1%
- 2McKesson13.6%
- 3Cigna9.4%
- 4Cardinal Health8.4%
- 5Centene6.2%
- 6Alvotech0%
Concentration
DistributedCR3 37.1%HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization
Winner-take-all deepeningConsistentPolarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Margin lens
- IQR%p
- 159.97
- Direction
- 축소
- Level
- 넓음
- Years
- 21
Value lens
- P90/P10
- 24.4
- Median P/B
- 3.02
- Level
- 넓음
- n
- 463
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Risk sensitivity — adverse assumptions
Metric changes under stated assumptions; not a forecast or investment advice.
Base metrics
- Operating margin
- 0.1%
- Interest coverage
- 0x
- Return on equity (ROE)
- —
Operating margin −5pp
Operating lossInterest coverageBase 0x adverse case -0.2x
Return on equity (ROE)Base — adverse case —
Revenue −15%
Interest coverage riskInterest coverageBase 0x adverse case 0x
Return on equity (ROE)Base — adverse case —
Interest rate +2pp
Interest coverage riskInterest coverageBase 0x adverse case 0x
Return on equity (ROE)Base — adverse case —
Interest coverage limit
Already below the limit by 31.2ppInterest coverage limit at an operating margin of 31.3%
Interest expense coverage threshold
Recent filings
Filings for overseas stocks are on the way. For now we cover Korean stocks only.
About Alvotech
- What technical signals does Alvotech (ALVO) have?
- Alvotech current technical signals: MA alignment (score 0.92).
- Is Alvotech a cup-and-handle pattern?
- No. Alvotech has no valid cup-and-handle signal right now.
- What are Alvotech's financials and valuation?
- Alvotech's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Quantus Signal · live data · not investment advice · Privacy Policy